OAKBROOK, ILL. (PRWEB) MARCH 27, 2023 Saint Louis University’s (SLU) Cannabis Science and Operations Undergraduate Certificate program is the winner of the 2023 UPCEA Outstanding Program Award, recognizing credit professional, continuing and/or online education programs at UPCEA member institutions for excellence in achieving their educational objectives. The honor was announced last week at the 2023 UPCEA Annual Conference in Washington, D.C. SLU partnered with Collegis …
NEW YORK, March 27, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, today announced the expansion of its brand portfolio with the launch of JAMS, a flavor-forward cannabis edibles brand designed to meet the needs of new cannabis consumers and those seeking an introduction to edibles. JAMS is now available in Florida and …
TORONTO, March 27, 2023 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, is pleased to announce the expansion of its medical portfolio with the launch of a new CBD chewing gum available to Starseed Medicinal patients on the Company’s medical platform. Expanding medical services with enriched …
Drivers treated for traffic-related injuries are more likely to test positive for high levels of alcohol (BAC ≥ 0.08 percent) than they are likely to test positive for elevated levels of THC (THC in blood ≥ 5 ng/mL), according to data published in the journal Addiction. Canadian investigators quantified and reviewed alcohol and THC concentrations in a cohort of nearly 7,000 injured drivers. …
Genova, Italy: Patients with a history of stroke are not at an increased risk of cardiovascular complications following the use of nabiximols (a/k/a Sativex – an oromucosal spray containing a balanced ratio of plant-derived THC and CBD), according to clinical trial data published in the journal Frontiers in Cardiovascular Medicine. Nabiximols is available by prescription in various countries, but not in the United States, for …
Jackson, MS: Lawmakers have approved legislation, House Bill 1158, amending provisions of the state’s medical cannabis access law. Proposed changes to the law will make it easier for qualified patients to register for the program and for physicians to participate in it. Language in the bill also expedites the timeline during which officials must approve patients’ registry applications. Other proposed changes require designated caregivers …
Tel Aviv, Israel: Tourette Syndrome (TS) patients report improvements in their quality of life and reductions in their use of prescription medications following cannabis therapy, according to data published in the journal Cannabis and Cannabinoid Research. Israeli investigators surveyed patients prior to and six-months following cannabis treatment. Subjects in the study consumed products containing roughly twice as much THC as CBD. Participants reported statistically …
Portland, OR: The administration of plant-derived CBD significantly reduces opioid cravings in animals, according to preclinical data published in the journal Addiction Neuroscience. Investigators affiliated with Washington State University in Spokane and with the Legacy Research Institute in Portland assessed the efficacy and safety profile of vaporized CBD in a cohort of female rats. They reported that rats provided with CBD were less likely …
WASHINGTON, March 23, 2023 /PRNewswire/ — Wine & Spirits Wholesalers of America (WSWA) today announced a commitment to advocating for the federal legalization and regulation of adult-use cannabis by applying regulations similar to those implemented for alcohol, making them the first alcohol industry trade association to do so. In a letter shared yesterday with members of Congress, the association presented a comprehensive and robust …
MIAMI, March 23, 2023 /PRNewswire/ — Benzinga Cannabis Capital Conference, the world’s largest and most successful cannabis investing and finance event, will return to Miami on April 11-12, 2023, at the legendary Fountainbleu Hotel. With registrations up 30% compared to last year, the event is set to bring together over 3,000 industry operators, investors, policymakers, and advocates to conduct business and forge new partnerships. The event …